Evidence map›Paper›PMID 19013269›Full record

ArticleCell2008

The safety on the TCR trigger.

Michael S Kuhns, Mark M Davis

Open access · bronzeAbstract readComment
In one paragraph

Article in Cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. T cell receptor (TCR) signaling in health and disease.Signal transduction and targeted therapy · 2021
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Basic residues in the T-cell receptor ζ cytoplasmic domain mediate membrane association and modulate signaling.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  19. Article
  20. Basal and antigen-induced exposure of the proline-rich sequence in CD3ε.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael S KuhnsDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Mark M Davis
Howard Hughes Medical Institute · USStanford University · US

Funding

T CELL RECEPTOR STRUCTURE AND EXPRESSIONR01AI022511 · NIAID · STANFORD UNIVERSITY · PI DAVIS, MARK MORRIS · 1985 to 2014
$3.3M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI022511
6 · The paper itself

Abstract

In this issue, Xu et al. (2008) provide evidence for a new mechanism of T cell receptor regulation. Prior to activation, basic residues in the cytoplasmic domain of the signaling subunits of the T cell receptor associate with the plasma membrane such that the key signaling tyrosines are sequestered in the bilayer.

Indexed as

Gene Expression RegulationAmino Acid MotifsAnimalsCell MembraneCytoplasmHumansLipid BilayersModels, BiologicalPhosphorylationProtein Structure, TertiaryReceptors, Antigen, T-CellSignal TransductionLipid BilayersReceptors, Antigen, T-Cell

Identifiers

PMID19013269
PMCPMC2905657
OpenAlexW1987725950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.